UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000043636
Receipt number R000049831
Scientific Title Study evaluating the effect of galvanic tongue stimulation on taste sensation.
Date of disclosure of the study information 2021/03/16
Last modified on 2023/03/17 17:16:07

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study evaluating the effect of galvanic tongue stimulation on taste sensation.

Acronym

Study evaluating the effect of galvanic tongue stimulation on taste sensation.

Scientific Title

Study evaluating the effect of galvanic tongue stimulation on taste sensation.

Scientific Title:Acronym

Study evaluating the effect of galvanic tongue stimulation on taste sensation.

Region

Japan


Condition

Condition

No

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study aimed to demonstrate the effect of galvanic tongue stimulation on taste sensation.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Taste intensity

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Food Other

Interventions/Control_1

Within 1 day, a participant ingests test food under galvanic tongue stimulation condition. A participant ingests test food under control condition.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >=

Gender

Male and Female

Key inclusion criteria

(1) Male and female subjects aged 20-65 years old who give written informed consent
(2) Give written informed consent, thoroughly understand the study

Key exclusion criteria

(1) Have a disease and/or previous history of heart disease, nerve disease and/or brain disease
(2) Have a serious disease of respiratory system
(3) Have an episodic disease such as epilepsia
(4) Wear a device affected by electric field and/or magnetic field
(5) Are pregnant, or are planning to become pregnant
(6) Are sensitive to alcohol
(7) Have allergies

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Homei
Middle name
Last name Miyashita

Organization

Meiji University

Division name

Faculty of Interdisciplinary Mathematical Sciences

Zip code

1640001

Address

4-21-1, Nakano, Nakano-ku, Tokyo, Japan

TEL

03-5343-8341

Email

homei@isc.meiji.ac.jp


Public contact

Name of contact person

1st name Ai
Middle name
Last name Sato

Organization

Kirin Holdings Company, Limited

Division name

Health Science Business Division

Zip code

1640001

Address

Nakano central South, 4-10-2, Nakano, Nakano-ku, Tokyo

TEL

080-2990-3796

Homepage URL


Email

Ai_sato@kirin.co.jp


Sponsor or person

Institute

Meiji University

Institute

Department

Personal name



Funding Source

Organization

Kirin Holdings Company, Limited

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Research Ethical Review Committee of Kirin Holdings Company, Ltd

Address

Nakano central South, 4-10-2, Nakano, Nakano-ku, Tokyo

Tel

03-6837-4128

Email

02976_Ni@kirin.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 03 Month 16 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled

100

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2020 Year 05 Month 28 Day

Date of IRB

2020 Year 05 Month 28 Day

Anticipated trial start date

2021 Year 04 Month 01 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded

2023 Year 01 Month 15 Day


Other

Other related information



Management information

Registered date

2021 Year 03 Month 16 Day

Last modified on

2023 Year 03 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049831


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name